Compare NBIX & KSPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBIX | KSPI |
|---|---|---|
| Founded | 1992 | 2008 |
| Country | United States | Kazakhstan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 16.9B |
| IPO Year | 1996 | 2023 |
| Metric | NBIX | KSPI |
|---|---|---|
| Price | $131.62 | $86.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 22 | 3 |
| Target Price | ★ $180.91 | $104.33 |
| AVG Volume (30 Days) | ★ 1.1M | 550.2K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 8.56% |
| EPS Growth | ★ 41.95 | N/A |
| EPS | ★ 4.67 | N/A |
| Revenue | ★ $161,626,000.00 | N/A |
| Revenue This Year | $24.73 | $3.90 |
| Revenue Next Year | $13.14 | $16.80 |
| P/E Ratio | $28.21 | ★ $7.12 |
| Revenue Growth | ★ 977.51 | N/A |
| 52 Week Low | $108.47 | $68.59 |
| 52 Week High | $160.18 | $99.11 |
| Indicator | NBIX | KSPI |
|---|---|---|
| Relative Strength Index (RSI) | 53.32 | 60.27 |
| Support Level | $124.62 | $71.17 |
| Resistance Level | $135.30 | $93.59 |
| Average True Range (ATR) | 3.41 | 3.51 |
| MACD | 0.17 | -0.02 |
| Stochastic Oscillator | 70.73 | 40.61 |
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.
Kaspi.kz JSC is the payment, marketplace, and Fintech ecosystem in Kazakhstan. The firm provides interconnected technologically seamless products and services that help people to pay, shop and manage their finances. Its operating segment includes the Payments Platform that connects its customers, which consist of both consumers and merchants, to facilitate cashless, digital transactions, the Marketplace Platform, which derives maximum revenue, connects merchants and consumers enabling merchants to increase their sales and consumers to buy a broad selection of products and services offered by a variety of merchants, and Fintech Platform that enables customers to manage their personal finances online and access consumer finance and deposit products through the Kaspi.kz Super App.